Informace o publikaci

Antioxidants in patients living with HIV on antiretrovirals

Autoři

HAVLÍČKOVÁ Kateřina SNOPKOVÁ Svatava POHANKA Miroslav SVAČINKA Radek HUSA Petr ZLÁMAL Filip FABIANOVÁ Lenka HUSA Petr

Rok publikování 2021
Druh Článek v odborném periodiku
Časopis / Zdroj MILITARY MEDICAL SCIENCE LETTERS
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.mmsl.cz/magno/mms/2021/mn2.php
Doi http://dx.doi.org/10.31482/mmsl.2021.005
Klíčová slova Antiretroviral therapy; glutathione; HIV; oxidative stress
Přiložené soubory
Popis Introduction Oxidative stress is considered predictors of diseases associated with aging (cardiovascular disease, neurodegenerative disease, malignancies, and others) in HIV-negative general population. Antioxidants were investigated in people living with HIV on antiretroviral treatment to determine whether they had an immunosenescent phenotype that might predispose to the development of premature age-related diseases. Clinical studies in this population are controversial. Methods The study was conducted among 213 subjects with HIV, including 172 subjects on antiretrovirals and 41 subjects before the initiation of treatment. The control group consisted of healthy HIV-negative adults. We compared the reduced glutathione and ferric reducing antioxidant power levels in HIV untreated and treated patients and controls. Significant differences were determined by appropriate statistical tests (t-test, Mann–Whitney U test, Kolmogorov–Smirnov test, ANOVA, Kruskal–Wallis test). Relationships between continuous variables were quantified using Spearman’s rank correlation coefficient. Results Glutathione levels were significantly lower in the treated group compared with the untreated group and controls (P ? 0.001). Differences in total antioxidant levels between groups were not found. Conclusions Significant decrease of antioxidants was found independent of the virologic status of HIV patients on antiretroviral treatment. Persistence of these abnormal parameters may contribute and predispose to the premature development of diseases associated with aging.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info